Chromosome 1p loss: A favorable prognostic factor in low‐grade gliomas
- 27 July 2005
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 58 (2), 322-326
- https://doi.org/10.1002/ana.20543
Abstract
Search for loss of heterozygosity on chromosomes 1p, 9p, 10q, and 19q, epidermal growth factor receptor (EGFR) gene amplification, and p53 expression was performed in a series of 131 low‐grade gliomas. The profile of molecular changes, clinical findings, and histology were subsequently correlated with the course of the disease, mainly progression‐free survival. When these parameters were considered as candidate variables in a multivariate analysis, only loss of heterozygosity on chromosome 1p was associated with increased progression‐free survival (hazard ratio, 0.521), indicating a major favorable prognostic role of this genetic alteration in low‐grade gliomas. Ann Neurol 2005;58:322–326Keywords
This publication has 10 references indexed in Scilit:
- Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p DeletionsJournal of Clinical Oncology, 2004
- Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomasActa Neuropathologica, 2004
- Genetic Signature of Oligoastrocytomas Correlates with Tumor Location and Denotes Distinct Molecular SubsetsThe American Journal of Pathology, 2002
- Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults With Supratentorial Low-Grade Glioma: Initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group StudyJournal of Clinical Oncology, 2002
- Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade GliomaJournal of Clinical Oncology, 2002
- Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysisInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular StudyJournal of Neuropathology and Experimental Neurology, 2001
- Subtyping of oligo-astrocytic tumours by comparative genomic hybridizationThe Journal of Pathology, 2001
- Molecular Genetic Evidence for Subtypes of OligoastrocytomasJournal of Neuropathology and Experimental Neurology, 1997
- A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844International Journal of Radiation Oncology*Biology*Physics, 1996